1. Hepatic TLR4 signaling in obese NAFLD. Sharifnia T, Antoun J, Verriere TG, Suarez G, Wattacheril J, Wilson KT, Peek RM, Abumrad NN, Flynn CR (2015) Am J Physiol Gastrointest Liver Physiol 309(4): G270-8
    › Primary publication · 26113297 (PubMed) · PMC4537925 (PubMed Central)
  2. Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids. Albaugh VL, Flynn CR, Cai S, Xiao Y, Tamboli RA, Abumrad NN (2015) J Clin Endocrinol Metab 100(9): E1225-33
    › Primary publication · 26196952 (PubMed) · PMC4570157 (PubMed Central)
  3. Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. Flynn CR, Albaugh VL, Cai S, Cheung-Flynn J, Williams PE, Brucker RM, Bordenstein SR, Guo Y, Wasserman DH, Abumrad NN (2015) Nat Commun : 7715
    › Primary publication · 26197299 (PubMed) · PMC4518285 (PubMed Central)
  4. A post-developmental genetic screen for zebrafish models of inherited liver disease. Kim SH, Wu SY, Baek JI, Choi SY, Su Y, Flynn CR, Gamse JT, Ess KC, Hardiman G, Lipschutz JH, Abumrad NN, Rockey DC (2015) PLoS One 10(5): e0125980
    › Primary publication · 25950913 (PubMed) · PMC4423964 (PubMed Central)
  5. Statistical strategies for microRNAseq batch effect reduction. Guo Y, Zhao S, Su PF, Li CI, Ye F, Flynn CR, Shyr Y (2014) Transl Cancer Res 3(3): 260-265
    › Primary publication · 25258704 (PubMed) · PMC4171948 (PubMed Central)
  6. SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient- and exercise-induced stress. Vassilopoulos A, Pennington JD, Andresson T, Rees DM, Bosley AD, Fearnley IM, Ham A, Flynn CR, Hill S, Rose KL, Kim HS, Deng CX, Walker JE, Gius D (2014) Antioxid Redox Signal 21(4): 551-64
    › Primary publication · 24252090 (PubMed) · PMC4085980 (PubMed Central)
  7. Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension. Fessel JP, Flynn CR, Robinson LJ, Penner NL, Gladson S, Kang CJ, Wasserman DH, Hemnes AR, West JD (2013) Am J Respir Cell Mol Biol 49(5): 778-87
    › Primary publication · 23742019 (PubMed) · PMC3931097 (PubMed Central)
  8. Effects of proximal gut bypass on glucose tolerance and insulin sensitivity in humans. Breitman I, Isbell JM, Saliba J, Jabbour K, Flynn CR, Marks-Shulman PA, Laferrère B, Abumrad NN, Tamboli RA (2013) Diabetes Care 36(4): e57
    › Primary publication · 23520381 (PubMed) · PMC3609508 (PubMed Central)
  9. Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis. Wattacheril J, Seeley EH, Angel P, Chen H, Bowen BP, Lanciault C, Caprioli RM, Abumrad N, Flynn CR (2013) PLoS One 8(2): e57165
    › Primary publication · 23451176 (PubMed) · PMC3581520 (PubMed Central)
  10. Cell-permeant peptide inhibitors of vasospasm and intimal hyperplasia. Osgood MJ, Flynn CR, Komalavilas P, Brophy C (2013) Vascular 21(1): 46-53
    › Primary publication · 23104826 (PubMed) · PMC4180429 (PubMed Central)